Observational studyBritish journal of anaesthesia2026
Single-dose intraoperative methadone and QTc interval: a prospective observational cohort investigation.
Observational study in British journal of anaesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundMethadone is increasingly used for perioperative care. High-dose methadone, for opioid use disorder or chronic pain, can prolong the cardiac QTc interval, which increases the risk of dangerous cardiac arrhythmias. This investigation evaluated single-dose perioperative methadone effects on QTc.
methodsThis prospective observational cohort study evaluated adults undergoing elective surgery under general anaesthesia. Patients received methadone i.v. or no methadone (typically fentanyl) at induction of anaesthesia (provider discretion). QTc was determined before and for 1 h after opioid administration and rate-corrected using Fridericia's formula (QTcF). The primary outcome was new-onset QTcF >500 ms. Secondary outcomes were any QTcF>500 ms; QTcF increase (ΔQTcF)>60 ms; QTcF>500 ms for >15 min; QTcF>450 ms (males) or >470 ms (females); maximum QTcF and ΔQTcF; and methadone dose vs QTcF or ΔQTcF.
resultsPatients were 59 (median; range 18-86) yr of age, and received methadone (n=282, median 20 mg, IQR [15-20], range 10-60 mg) or no methadone (n=265, typically fentanyl, 250 μg [100, 350], 0-750 μg). New QTcF>500 ms occurred in 2.5% of patients receiving methadone and 8.3% receiving no methadone (relative risk [RR] 0.34, 95% confidence interval [0.16-0.75] P=0.009). Secondary outcomes with methadone vs no methadone found that any QTcF>500 ms occurred less (3.5% vs 8.3%, RR 0.43); ΔQTcF>60 ms occurred less (4.6% vs 12.1%, RR 0.39); maximum ΔQTcF was less (28 ms vs 37 ms); and sex-specific thresholds were exceeded less (22.3% vs 33.6%) (all P<0.03). There was no correlation between methadone dose and QTcF or ΔQTcF.
conclusionsA single-dose at induction of methadone i.v. did not prolong QTcF. Methadone had no clinically meaningful QTcF effects, specifically or in comparison with no use of methadone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.